Composition
- Active ingredients
- NICOTINE POLACRILEX EQ 2MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NICOTINE POLACRILEX EQ 2MG BASE · Gum, chewingThis page
- NICOTINE POLACRILEX EQ 4MG BASE · Gum, chewingANDA077656-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA077658.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Thrive
- Active substance
- nicotine polacrilex
- Route
- Buccal
- Dosage form
- Gum, chewing
- Applicant
- Glaxosmithkline Cons
- Status
- Discontinued
- FDA approval
- 19 Jun 2007
- Application
- ANDA077658-001